- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, the reporter learned from the University of Science and Technology of China that Professor Hu Yanlei's team and his collaborators in the micro-nano Engineering Laboratory of the School of Engineering Science and Technology of the School have prepared a magnetic-responsive double-God origami robot that can be used for cross-scale droplet manipulation using femtosecond laser micro-nano man...
Professor Zhang Peilei's team from Shanghai University of Engineering and Technology, in collaboration with the research team from Warwick University and Autuch (Shanghai) Laser Technology Co., Ltd., published a review paper titled "A review of ultra shot pulse laser micromachining of wide bandgap semiconductor materials: SiC and GaN" in the international journal Materials Science in Semiconductor...
Credo Technology Group Holding Ltd announced today the launch of the industry's first Dove 800 850G digital signal processor IC, which has been optimized for linear receiving optical devices and is also known as semi retiming linear optical devices in the industry. In LRO transceivers or active optical cables, only the transmission path from the electrical input to the output of the optical path i...
Introduction to FLUOVIEW ™ The FV4000 confocal laser scanning microscope and FV4000MPE multiphoton laser scanning microscope have made breakthroughs in imaging technology, enabling researchers to make new scientific discoveries. The FV4000 and FV4000MPE microscopes aim to redefine scientific imaging, providing higher accuracy, lower noise, and higher sensitivity, setting new standards for im...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...